A new multicenter trial finds that taking silymarin (milk thistle) has no effect on serum ALT or levels of the hepatitis C virus in people with chronic hepatitis C infection.
A new multicenter trial finds that taking silymarin (milk thistle) has no effect on serum ALT or levels of the hepatitis C virus in people with chronic hepatitis C infection.